guidelines on qualification - appendix 6...136 guideline on qualification – updated text proposed...

17
Working document QAS/16.673/Rev.2 September 2018 Draft document for comments GUIDELINES ON QUALIFICATION - APPENDIX 6 1 VALIDATION 2 3 (September 2018) 4 DRAFT FOR COMMENTS 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 © World Health Organization 2018 22 23 All rights reserved. 24 25 This draft is intended for a restricted audience only, i.e. the individuals and organizations having received this draft. The draft 26 may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any 27 form or by any means outside these individuals and organizations (including the organizations' concerned staff and member 28 organizations) without the permission of the World Health Organization. The draft should not be displayed on any website. 29 30 Please send any request for permission to: 31 32 Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms, Regulation of Medicines and 33 other Health Technologies, Department of Essential Medicines and Health Products, World Health Organization, CH-1211 34 Geneva 27, Switzerland, fax: (41-22) 791 4856; email: [email protected]. 35 36 The designations employed and the presentation of the material in this draft do not imply the expression of any opinion 37 whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its 38 authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines 39 for which there may not yet be full agreement. 40 41 The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended 42 by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions 43 excepted, the names of proprietary products are distinguished by initial capital letters. 44 45 All reasonable precautions have been taken by the World Health Organization to verify the information contained in this draft. 46 However, the printed material is being distributed without warranty of any kind, either expressed or implied. The responsibility 47 for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for 48 damages arising from its use. 49 50 This draft does not necessarily represent the decisions or the stated policy of the World Health Organization. 51 Please forward any comments you may have on the attached text to Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms ([email protected]) with a copy to Mrs Xenia Finnerty ([email protected]) by 15 November 2018. Medicines Quality Assurance working documents will only be sent out electronically and will also be placed on the Medicines website for comments under “Current projects”. If you have not already received our draft working documents, please send your email address (to [email protected]) and we will add it to our electronic mailing list.

Upload: others

Post on 18-Apr-2020

30 views

Category:

Documents


0 download

TRANSCRIPT

Working document QAS/16.673/Rev.2

September 2018

Draft document for comments

GUIDELINES ON QUALIFICATION - APPENDIX 6 1

VALIDATION 2

3

(September 2018) 4

DRAFT FOR COMMENTS 5

6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

© World Health Organization 2018 22 23 All rights reserved. 24 25 This draft is intended for a restricted audience only, i.e. the individuals and organizations having received this draft. The draft 26 may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any 27 form or by any means outside these individuals and organizations (including the organizations' concerned staff and member 28 organizations) without the permission of the World Health Organization. The draft should not be displayed on any website. 29 30 Please send any request for permission to: 31 32 Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms, Regulation of Medicines and 33 other Health Technologies, Department of Essential Medicines and Health Products, World Health Organization, CH-1211 34 Geneva 27, Switzerland, fax: (41-22) 791 4856; email: [email protected]. 35 36 The designations employed and the presentation of the material in this draft do not imply the expression of any opinion 37 whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its 38 authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines 39 for which there may not yet be full agreement. 40 41 The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended 42 by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions 43 excepted, the names of proprietary products are distinguished by initial capital letters. 44 45 All reasonable precautions have been taken by the World Health Organization to verify the information contained in this draft. 46 However, the printed material is being distributed without warranty of any kind, either expressed or implied. The responsibility 47 for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for 48 damages arising from its use. 49 50 This draft does not necessarily represent the decisions or the stated policy of the World Health Organization. 51

Please forward any comments you may have on the attached text to Dr Sabine Kopp, Group

Lead, Medicines Quality Assurance, Technologies, Standards and Norms ([email protected])

with a copy to Mrs Xenia Finnerty ([email protected]) by 15 November 2018.

Medicines Quality Assurance working documents will only be sent out electronically and

will also be placed on the Medicines website for comments under “Current projects”. If

you have not already received our draft working documents, please send your email

address (to [email protected]) and we will add it to our electronic mailing list.

.

Working document QAS/16.673/Rev.2

page 2 52 SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OF DOCUMENT QAS/16.673/Rev.2: 53

GUIDELINES ON QUALIFICATION - APPENDIX 6 54

VALIDATION 55 56

Discussion of proposed need for revision in view of the current

trends in validation during informal consultation on data

management, bioequivalence, good manufacturing practices

(GMP) and medicines’ inspection.

29 June –

1 July 2015

Preparation of draft proposal for revision of the main text and

several appendices by specialists in collaboration with the

Medicines Quality Assurance Group and Prequalification Team

(PQT)-Inspections, based on the feedback received during the

meeting and from PQT-Inspections, draft proposals developed

on the various topics by specialists, as identified in the

individual working documents.

July 2015–

April 2016

Presentation of the progress made to the fiftieth meeting of the

WHO Expert Committee on Specifications for Pharmaceutical

Preparations (ECSPP).

12–16 October 2015

Discussion at the informal consultation on good practices for

health products manufacture and inspection, Geneva. 4–6 April 2016

Preparation of revised text by Dr A.J. van Zyl, participant at

the above-mentioned consultation, based on the feedback

received during and after the informal consultation by the

meeting participants and members of PQT-Inspections.

May 2016

Circulation of revised working document for public

consultation. June 2016

Consolidation of comments received and review of feedback. August–September 2016

Presentation to the fifty-first meeting of the ECSPP. 17–21 October 2016

Preparation of revised text by Dr A.J. van Zyl based on the

feedback received during the public consultation and the fifty-

first ECSPP meeting.

March 2017

Circulation of revised working document for public

consultation.

February 2018

Consolidation of comments received and review of feedback. May–June 2018

Discussion at the informal consultation on GMP and

inspection, Geneva. 11-12 July 2018

Cleaning-up of the changes agreed during the consultation and

circulation of revised working document for another round of

public consultation.

August - September 2018

Working document QAS/16.673/Rev.2

page 3

57 58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

Consolidation of comments received and review of feedback. October-November 2018

Presentation to the fifty-third meeting of ECSPP. 22–26 October 2018

Any other follow-up action as required. …

Working document QAS/16.673/Rev.2

page 4

BACKGROUND INFORMATION 92

93

The need for revision of the published Supplementary guidelines on good manufacturing 94

practices: validation (World Health Organization (WHO) Technical Report Series, No. 937, 95

2006, Annex 4) was identified by the Prequalification of Medicines Programme and a draft 96

document was circulated for comments in early 2013. The focus of the revision was the 97

Appendix on non-sterile process validation (Appendix 7), which had been revised and was 98

adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations 99

(ECSPP) at its forty-ninth meeting in October 2014. 100

101

The main text was sent out for consultation as a working document QAS/15.639 entitled 102

Guidelines on validation which constitute the general principles of the new guidance on 103

validation. 104

105

The draft on the specific topics, the appendices to this main text, will follow. One of them, the 106

Validation on qualification of systems, utilities and equipment, newly entitled Guidelines on 107

qualification, constitutes this working document. 108

109

The following is an overview on the appendices that are intended to complement the general text 110

on validation: 111

112

Appendix 1 113

Validation of heating, ventilation and air-conditioning systems (HVAC) 114

will be replaced by cross-reference to the WHO Guidelines on GMP for HVAC 115

systems for considerations in qualification of HVAC systems 116

(– Annex 8 in TRS 1010, 2018) 117

118

Appendix 2 119

Validation of water systems for pharmaceutical use 120

Working document QAS/16.673/Rev.2

page 5

will be replaced by cross-reference to WHO Guidelines on water for pharmaceutical 121

use for consideration in qualification of water purification systems 122

123

Appendix 3 124

Cleaning validation – consensus to retain 125

126

Appendix 4 127

Analytical method validation 128

will be replaced by update – working document QAS/16.671 129

130

Appendix 5 131

Validation of computerized systems 132

will be replaced by update – working document QAS/16.667 133

134

Appendix 6 135

Guideline on Qualification – updated text proposed in this working document 136

(new title) 137

138

Appendix 7 139

Non-sterile process validation – update already published as Annex 3, WHO Technical 140

Report Series, No. 992, 2015 141

142

Brief background on the changes in this document 143

144

There was some confusion regarding the title. It is therefore suggested to change the title to 145

GUIDELINES ON QUALIFICATION. In this way, the general principles in qualification are 146

addressed which can be applied for systems, equipment, and so on. 147

148

Based on the comments, the general chapters on objective and scope were written to make it 149

clear that the guidelines address principles of qualification that can be applied, as appropriate, to 150

Working document QAS/16.673/Rev.2

page 6

premises, systems, utilities and equipment and to include the application of risk management 151

principles. 152

153

Moreover, duplication was removed, logical flow of concepts addressed and aligned with 154

international texts and the comments. The V Model has been removed based on the feedback 155

received. In the former published text on qualification, protocol formats were included. These 156

protocol formats were extracted from training materials and were intended to serve as examples. 157

In view of the feedback that seemingly manufacturers took them as absolute examples to be 158

used, these examples have been removed in the current version. 159

160 161

162

Working document QAS/16.673/Rev.2

page 7

APPENDIX 6 163

GUIDELINES ON QUALIFICATION 164

165

1. Principle 166

2. Scope 167

3. Glossary 168

4. General 169

5. User requirement specifications 170

6. Design qualification 171

7. Factory acceptance test and site acceptance test 172

8. Installation qualification 173

9. Operational qualification 174

10. Performance qualification 175

11. Periodic review and requalification 176

177

1. PRINCIPLE 178

179

1.1 In principle, premises, systems, utilities and equipment should be appropriately designed, 180

installed, qualified, operated, cleaned and maintained to suit their intended purpose. 181

182

1.2 Quality management systems should be in place to ensure that these remain in a qualified 183

state throughout their life cycle. 184

185

1.3 Products should be manufactured on qualified equipment. 186

187

1.4 Manufacturers who may use an alternative verification framework to achieve qualification 188

should ensure the qualification expectations within this guide are satisfied. 189

190

191

Working document QAS/16.673/Rev.2

page 8

2. SCOPE 192

193

2.1 These guidelines describe the general approach to qualification, for example, premises, 194

systems, computerized system, utilities and equipment. 195

196

2.2 The principles in these guidelines may also be applied to the qualification of instruments, 197

analytical instruments and testing devices, where appropriate. 198

199

2.3 These may include and are not limited to: certain rooms; water purification systems; 200

cleaning systems; heating, ventilation and air conditioning systems; compressed air systems; gas 201

systems; steam systems; as well as production equipment and analytical instruments. 202

203

2.4 Separate guidelines in this series address other principles in validation such as process 204

validation and cleaning validation (see references at the end of this document). 205

2.5 The principle can be used when de-commissioning equipment to show that it remains fit 206

for its purpose throughout the life cycle. 207

208

3. GLOSSARY 209

210

computerized system. A computerized system collectively controls the performance 211

and execution of one or more automated processes and/or functions. It includes computer 212

hardware, software, peripheral devices, networks and documentation, for example, manuals and 213

standard operating procedures (SOPs), as well as personnel interacting with hardware and 214

software. 215

216

design qualification. Documented evidence that, for example, the premises, supporting 217

systems, utilities and equipment have been designed for their intended purposes and in 218

accordance with the requirements of good manufacturing practices (GMP). 219

220

Working document QAS/16.673/Rev.2

page 9

factory acceptance test. A test conducted, usually at the vendor’s premises, to verify 221

that the system, equipment or utility, as assembled or partially assembled, meets approved 222

specifications. (new) 223

224

installation qualification. The performance of tests to ensure that the installations (such 225

as machines, measuring devices, utilities and manufacturing areas) used in a manufacturing 226

process are appropriately selected and correctly installed and operate in accordance with 227

established specifications. 228

229

operational qualification. Documented verification that the system or subsystem 230

performs as intended over all anticipated operating ranges. 231

232

performance qualification. Documented verification that the equipment or system 233

operates consistently and gives reproducibility within defined specifications and parameters for 234

prolonged periods. (In the context of systems, the term “process validation” may also be used.) 235

236

site acceptance test. A test conducted at the site of use to verify that the system, 237

equipment or utility, as assembled or partially assembled meets approved specifications. (new) 238

239

system. A regulated pattern of interacting activities and techniques that are united to 240

form an organized whole. 241

242

user requirement specifications. An authorized document that defines the requirements 243

for use of the system, equipment or utility in its intended production environment. (amended) 244

245

utility. A system consisting of one or more components to form a structure designed to 246

collectively operate, function or perform and provide a service such as electricity, water, 247

ventilation or other. (new) 248

249

Working document QAS/16.673/Rev.2

page 10

4. GENERAL 250

251

Note: The remainder of the text in these guidelines will refer to utilities and equipment as 252

examples, even though the principles may be applicable to others such as premises and systems. 253

254

4.1 The validation master plan, or other relevant document, should specify the policy, 255

organization, planning, scope and stages applied in qualification on site, and should cover, for 256

example, production, quality control and engineering. 257

258

4.2 Quality risk management principles should be applied in qualification. These include: 259

260

A clear understanding of the system, and the role it plays in 261

establishing/protecting the process and quality and all of the potential ways (risks) the 262

process or quality could be impacted by failures, events, errors, or time/use-based factors 263

(deterioration, out of tolerance instruments, wear and tear, and so on); 264

Defining all of the Design, Procedural and/or Quality System Controls required to 265

protect against these potential risks. These controls either mitigate/reduce the risks 266

and/or detect the impact to quality or process – should the risk occur. (To ensure the 267

“failure” does not impact final product quality); 268

Compiling evidence during the design, engineering, commissioning and 269

qualification to demonstrate that all of these required “controls” have been properly 270

implemented and verified. (Including “function” where applicable – such as alarms on 271

operating parameters); 272

Appropriate control and oversight of change once the controls have been verified. 273

274

4.3 The scope and extent of qualification and requalification should be determined based on 275

the principles of impact assessment and risk management principles. 276

277

4.4 Qualification should be executed by trained personnel. Training records should be 278

maintained. 279

Working document QAS/16.673/Rev.2

page 11

4.5 Where appropriate, new premises, systems, utilities and equipment should be subjected to 280

all stages of qualification. This includes the preparation of user requirement specifications 281

(URS), design qualification (DQ), installation qualification (IQ), operational qualification (OQ) 282

and performance qualification (PQ). 283

284

4.6 Justification should be provided where it is decided that not all stages of qualification are 285

required. 286

287

4.7 Qualification should be done in accordance with predetermined and approved 288

qualification protocols. The protocol should specify the prerequisites and test details, including 289

acceptance criteria. 290

291

4.8 The results of the qualification should be recorded and reflected in qualification reports. 292

293

4. 9 A qualification report prepared at the completion of each protocol or stage of 294

qualification (Installation/Operational/Performance) should include, or reference as appropriate, 295

the following: 296

297

test results, including supporting calculations, documentation and raw/original 298

data, 299

test failures, 300

protocol departures, 301

recommendations and justification for issue resolution, and 302

conclusions. 303

304

4.10 There should be a logical sequence for executing qualification, such as premises (rooms), 305

then utilities and equipment. 306

307

4.11 Normally, qualification stages should be sequential. (For example, operational 308

qualification should follow after the successful completion of installation qualification.) In some 309

Working document QAS/16.673/Rev.2

page 12

cases, different stages of qualification may be executed concurrently. This should be justified 310

and documented in the validation master plan (or qualification protocol). 311

312

4.12 Equipment should be released for routine use only once there is documented evidence 313

that the qualification has been successful. 314

315

4.13 Certain stages of the qualification may be done by a supplier or a third party, subject to 316

the conditions and responsibilities as defined in a written agreement between the parties. The 317

contract giver remains responsible to ensure that the qualification is done in accordance with the 318

principles of GMP. 319

320

4.14 The relevant documentation associated with qualification, including SOPs, specifications 321

and acceptance criteria, certificates and manuals, should be available. 322

323

4.15 Utilities and equipment should be maintained in a qualified state and should be 324

periodically reviewed for the need for requalification. Requalification should be considered 325

when changes are made. 326

327

5. USER REQUIREMENT SPECIFICATIONS 328

329

5.1 URS should be prepared for, but not limited to, utilities and equipment, as appropriate. 330

331

5.2 URS should be used at later stages in qualification to verify that the purchased and 332

supplied utility or equipment is in accordance with the user’s needs. 333

334

6. DESIGN QUALIFICATION 335

336

6.1 DQ should demonstrate that the system, as designed, is appropriate for its intended use as 337

defined in the URS. 338

339

Working document QAS/16.673/Rev.2

page 13

6.2 A suitable supplier should be selected and approved for the relevant utility or equipment. 340

341

7. FACTORY ACCEPTANCE TEST AND SITE ACCEPTANCE TEST 342

343

7.1 Where a utility or equipment is assembled, or partially assembled at a site other than that 344

of the purchaser or end-user, testing and verification may be done, based on quality risk 345

management principles, to ensure that it is appropriate and ready for dispatch. 346

347

7.2 The checks and tests during factory acceptance test (FAT) should be recorded. 348

349

7.3 The acceptability of the assembly and overall status of the utility or equipment should be 350

described in a conclusion of the report for the FAT, prior to shipment. 351

352

7.4 Tests, based on quality risk management principles, may be performed to verify the 353

acceptability of the utility or equipment when it is received at the end-user. This is a site 354

acceptance test (SAT). 355

356

7.5 The results of the tests should be evaluated and the outcome of the acceptability of the 357

utility or equipment should be recorded in the conclusion section of the report for the SAT. 358

359

8. INSTALLATION QUALIFICATION 360

361

8.1 Utilities and equipment should be correctly installed, in an appropriate location. 362

363

8.2 There should be documented evidence of the installation. This should be in accordance 364

with the IQ protocol which contains all the relevant details. 365

366

8.3 IQ should include identification and installation verification of relevant components 367

identified, e.g. services, controls and gauges. 368

369

Working document QAS/16.673/Rev.2

page 14

8.4 Identified measuring, control and indicating devices, should be calibrated on site unless 370

otherwise appropriately justified. The calibration should be traceable to national or international 371

standards. Traceable certificates should be available. 372

373

8.5 Deviations and non-conformances, including those from URS, DQ and acceptance 374

criteria specified and observed during installation, should be recorded, investigated, and 375

corrected or justified. 376

377

8.6 Normally, the outcome of the IQ should be recorded in the conclusion of the report, 378

before OQ is started. 379

380

9. OPERATIONAL QUALIFICATION 381

382

9.1 Requirements and procedures for operation (or use), calibration, maintenance and 383

cleaning should normally be prepared normally before OQ and approved prior to PQ. 384

385

9.2 Utilities and equipment should operate correctly and their operation should be verified in 386

accordance with an OQ protocol. OQ normally follows IQ but, depending on the complexity of 387

utility or equipment, it may be performed as a combined installation/operation qualification 388

(IOQ). This should be justified and documented in the validation master plan (or qualification 389

protocol). 390

391

9.3 OQ should include, but is not limited to, the following: 392

393

­ tests that have been developed from the knowledge of processes, systems and 394

equipment to ensure the utility or equipment is operating as designed; and 395

396

­ tests to confirm upper and lower operating limits, and/or “worst case” conditions. 397

398

Working document QAS/16.673/Rev.2

page 15

9.4 Training of operators for the utilities and equipment should be provided and training 399

records maintained. 400

401

9.5 Calibration, cleaning, maintenance, training and related tests and results should be 402

verified to be acceptable. 403

404

9.6 Deviations and non-conformances observed should be recorded, investigated and 405

corrected or justified. 406

407

9.7 The results for the verification of operation should be documented in the OQ report. 408

409

The outcome of the OQ should be recorded in the conclusion of the report, normally before PQ is 410

started. 411

412

10. PERFORMANCE QUALIFICATION 413

414

10.1 PQ should normally follow the successful completion of IQ and OQ. In some cases, it 415

may be appropriate to perform PQ in conjunction with OQ or process validation. This should be 416

justified and documented in the validation master plan (or qualification protocol). 417

418

10.2 PQ should include, but is not limited to, the following: 419

420

­ tests using production materials, qualified substitutes or simulated products 421

proven to have equivalent behaviour under normal operating conditions with worst case 422

scenario and batch sizes where appropriate; and 423

­ tests should cover the intended operating range. 424

425

10.3 Utilities and equipment should consistently perform in accordance with their design 426

specifications and URS. The performance should be verified in accordance with a PQ protocol. 427

428

Working document QAS/16.673/Rev.2

page 16

10.4 There should be records (for example, a PQ report) for the PQ to indicate the satisfactory 429

performance over a predefined period of time. Manufacturers should justify the period over 430

which PQ is done. 431

432

11. PERIODIC REVIEW AND REQUALIFICATION 433

434

11.1 Utilities and equipment should be maintained in a qualified state through the life cycle of 435

the utility or equipment. 436

437

11.2 Utilities and equipment should be reviewed periodically to confirm that they remain in a 438

qualified state or to determine the need for requalification. 439

440

11.3 Where the need for requalification is identified, this should be performed. 441

442

11.4 Risk management principles should be applied in the review and requalification and the 443

possible impact of small changes over a period of time should further be considered (such as, 444

through change control). 445

446

11.5 Risk management principles may include factors such as calibration, verification, 447

maintenance data and other information. 448

449

11.6 The qualification status and requalification due dates should be documented, for example, 450

in a qualification matrix, schedule or plan. 451

452

11.7 In case a utility or equipment in use is identified, where it had not been subjected to 453

qualification, a qualification protocol should be prepared where elements of URS, design 454

specifications, operation and performance are verified for acceptability. The outcome of this 455

qualification should be recorded in a report. 456

457

458

Working document QAS/16.673/Rev.2

page 17

Reference documents for additional reading 459

460

[Note from the Secretariat: The references below will be updated upon finalization of the related 461

texts.] 462

463

See WHO TRS 970, 2012, Annex 2, for aspects to be considered for inclusion in qualification of 464

water purification systems. 465

466

See WHO TRS 1010, 2018, Annex 8, for aspects to be considered for inclusion in qualification 467

of heating, ventilation and air-conditioning (HVAC) systems. 468

469

See WHO TRS XXX for aspects to be considered for inclusion in qualification and validation of 470

computerized systems (QAS working document QAS/16.667). 471

472

See WHO TRS 992, 2015, Annex 3, for aspects to be considered in process validation. 473

474

See WHO TRS XXX for aspects to be considered in analytical method validation (QAS working 475

document QAS/16.671) 476

477

*** 478